
New clinical trial combining two immunotherapeutic approaches to open
A new clinical trial for patients who have undergone standard chemotherapy and surgery with recurring (or unresponsive) pleural mesothelioma will open later this year at
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.

A new clinical trial for patients who have undergone standard chemotherapy and surgery with recurring (or unresponsive) pleural mesothelioma will open later this year at

Each year, the Mesothelioma Applied Research Foundation presents awards to those in the community who have made an extraordinary impact in the fight against mesothelioma.

Since 2004, the International Symposium on Malignant Mesothelioma (organized by the Mesothelioma Applied Research Foundation) has become the annual destination for mesothelioma patients, their families,

The Mesothelioma Applied Research Foundation (Meso Foundation) is pleased to announce that R. Taylor Ripley, MD and Jason M. Foster, MD have joined the organization’s

With September’s passage of the appropriations bill, which included funding for a feasibility study, the preliminary steps in the development of a National Mesothelioma Patient Registry

Today, the Mesothelioma Applied Research Foundation (Meso Foundation) announced the award recipients of its 2018 grant cycle funding for promising mesothelioma research. About the Mesothelioma

The Fiscal Year 2019 (FY19) funding bill for the U.S. Department of Health and Human Services (HHS) that Congress passed in September includes $100,000 for

The Mesothelioma Applied Research Foundation (Meso Foundation) announced today that William (Bill) N. Ziegler has been elected to join its board of directors. He will